| Literature DB >> 29943608 |
Gabi A De Jager1, Talitha Crowley, Tonya M Esterhuizen.
Abstract
BACKGROUND: South Africa has experienced a substantial increase in access to antiretroviral treatment (ART) in recent years. Effective strategies to manage access to treatment need to be incorporated into and implemented in ART programmes. Antiretroviral treatment adherence clubs are a new strategy that is being implemented in various parts of South Africa. AIM: The aim of the study was to investigate treatment adherence and patient satisfaction of stable human immunodeficiency virus (HIV) patients on ART in ART adherence clubs and clinics.Entities:
Keywords: HIV; PHC clinics; adherence clubs; patient satisfaction
Mesh:
Substances:
Year: 2018 PMID: 29943608 PMCID: PMC6018455 DOI: 10.4102/phcfm.v10i1.1759
Source DB: PubMed Journal: Afr J Prim Health Care Fam Med ISSN: 2071-2928
Biographical data.
| Variable | Clinic | Club | Total | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valid % | Mean | Median | SD | Valid % | Mean | Median | SD | Valid % | Mean | Median | SD | |||||
| 0.83 | ||||||||||||||||
| Men | 51 | 23.4 | - | - | - | 24 | 24.5 | - | - | - | 75 | 23.7 | - | - | - | - |
| Women | 167 | 76.6 | - | - | - | 74 | 75.5 | - | - | - | 241 | 76.3 | - | - | - | - |
| Total | 218 | 100 | - | - | - | 98 | 100.0 | - | - | - | 316 | 100.0 | - | - | - | - |
| 0.03 | ||||||||||||||||
| Xhosa | 98 | 44.2 | - | - | - | 57 | 58.1 | - | - | - | 155 | 48.4 | - | - | - | - |
| English | 40 | 18.0 | - | - | - | 18 | 18.4 | - | - | - | 58 | 18.2 | - | - | - | - |
| Afrikaans | 84 | 37.8 | - | - | - | 23 | 23.5 | - | - | - | 107 | 33.4 | - | - | - | - |
| Total | 222 | 100.0 | - | - | - | 98 | 100.0 | - | - | - | 320 | 100.0 | - | - | - | - |
| < 0.01 | ||||||||||||||||
| Full- time | 63 | 28.4 | - | - | - | 40 | 40.8 | - | - | - | 103 | 32.2 | - | - | - | - |
| Part- time | 30 | 13.5 | - | - | - | 20 | 20.4 | - | - | - | 50 | 15.6 | - | - | - | - |
| Unemployed | 129 | 58.1 | - | - | - | 38 | 38.8 | - | - | - | 167 | 52.2 | - | - | - | - |
| Total | 222 | 100.0 | - | - | - | 98 | 100.0 | - | - | - | 320 | 100.0 | - | - | - | - |
| 0.08 | ||||||||||||||||
| No other illnesses | 155 | 69.8 | - | - | - | 77 | 78.6 | - | - | - | 232 | 72.5 | - | - | - | - |
| One other illness | 56 | 25.2 | - | - | - | 20 | 20.4 | - | - | - | 76 | 23.8 | - | - | - | - |
| Two other illnesses | 10 | 4.5 | - | - | - | 1 | 1.0 | - | - | - | 11 | 3.4 | - | - | - | - |
| Three or more other illnesses | 1 | 0.5 | - | - | - | 0 | 0.0 | - | - | - | 1 | 0.3 | - | - | - | - |
| Total | 222 | 100.0 | - | - | - | 98 | 100.0 | - | - | - | 320 | 100.0 | - | - | - | - |
| 0.27 | ||||||||||||||||
| No | 30 | 13.6 | - | - | - | 9 | 9.2 | - | - | - | 39 | 12.2 | - | - | - | - |
| Yes | 191 | 86.4 | - | - | - | 89 | 90.8 | - | - | - | 280 | 87.8 | - | - | - | - |
| Total | 221 | 100.0 | - | - | - | 98 | 100.0 | - | - | - | 319 | 100.0 | - | - | - | - |
| Age | 221 | 100.0 | 39.4 | 40.0 | 9.2 | 95 | 100.0 | 39.4 | 39.0 | 9.4 | 316 | 100.0 | 39.4 | 39.0 | 9.3 | 0.99 |
| Educational level | 217 | 100.0 | 9.2 | 10.0 | 2.8 | 98 | 100.0 | 9.1 | 10.0 | 2.7 | 315 | 100.0 | 9.2 | 10.0 | 2.8 | 0.90 |
| Monthly income | 214 | 100.0 | 1034.5 | 0.0 | 1331.8 | 98 | 100.0 | 1617 | 1200.0 | 2088.8 | 312 | 100.0 | 1217.4 | 500.0 | 1627.6 | 0.02 |
| Number of pills taken | 222 | 100.0 | 3.8 | 3.0 | 3.2 | 98 | 100.0 | 3.4 | 3.0 | 2.3 | 320 | 100.0 | 3.7 | 3.0 | 2.9 | 0.44 |
Human immunodeficiency virus-related data.
| Variable | Clinic | Club | Total | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valid % | Mean | Median | SD | Valid % | Mean | Median | SD | Valid % | Mean | Median | SD | |||||
| < 0.001 | ||||||||||||||||
| Yes | 164 | 77.7 | - | - | - | 95 | 98.9 | - | - | - | 259 | 84.4 | - | - | - | - |
| No | 47 | 22.3 | - | - | - | 1 | 1.1 | - | - | - | 48 | 15.6 | - | - | - | - |
| Total | 211 | 100.0 | - | - | - | 96 | 100.0 | - | - | - | 307 | 100.0 | - | - | - | - |
| 212 | 100.0 | 2.48 | 0.93 | 96 | 100.0 | 2.08 | - | 0.25 | 308 | 100.0 | 2.35 | - | 0.80 | 0.280 | ||
| 0.100 | ||||||||||||||||
| 1–5 years ago | 96 | 33.6 | - | - | - | 44 | 47.3 | - | - | - | 140 | 48.9 | - | - | - | - |
| 6–10 years ago | 73 | 25.5 | - | - | - | 44 | 47.3 | - | - | - | 117 | 40.9 | - | - | - | - |
| More than 10 years ago | 24 | 8.4 | - | - | - | 5 | 5.4 | - | - | - | 29 | 10.1 | - | - | - | - |
| Total | 193 | 100.0 | - | - | - | 93 | 100.0 | - | - | - | 286 | 100.0 | - | - | - | - |
| 221 | 100.0 | 4.5 | 4.0 | 2.3 | 98 | 100.0 | 5.4 | 5 | 2.4 | 319 | 100.0 | 4.8 | 4.3 | 2.4 | < 0.010 | |
Treatment adherence: Likert-scale items.
| Variable | Clinic | Club | Total | ||||
|---|---|---|---|---|---|---|---|
| Valid % | Valid % | Valid % | |||||
| < 0.01 | |||||||
| Within the week | 22 | 9.9 | 9 | 9.2 | 31 | 9.7 | - |
| 1–2 weeks ago | 16 | 7.2 | 4 | 4.1 | 20 | 6.3 | - |
| 2–4 weeks ago | 6 | 2.7 | 4 | 4.1 | 10 | 3.1 | - |
| 1–3 months ago | 14 | 6.3 | 5 | 5.1 | 19 | 5.9 | - |
| More than 3 months ago | 25 | 11.3 | 0 | 0.0 | 25 | 7.8 | - |
| Never | 139 | 62.6 | 76 | 77.6 | 215 | 67.2 | - |
| Total | 222 | 100.0 | 98 | 100.0 | 320 | 100.0 | - |
| 0.66 | |||||||
| Very poor | 3 | 1.4 | 0 | 0.0 | 3 | 1.4 | - |
| Poor | 3 | 1.4 | 0 | 0.0 | 3 | 1.4 | - |
| Fair | 7 | 3.2 | 1 | 1.0 | 8 | 2.5 | - |
| Good | 33 | 14.9 | 14 | 14.3 | 47 | 14.7 | - |
| Very good | 57 | 25.7 | 30 | 30.6 | 87 | 27.2 | - |
| Excellent | 119 | 53.6 | 53 | 54.1 | 172 | 53.8 | - |
| Total | 222 | 100.0 | 98 | 100.0 | 320 | 100.0 | - |
Logistic regression model for estimated adherence (adherent vs. non-adherent).
| Estimated adherence | Odds ratio | 95% Confidence interval | |
|---|---|---|---|
| Attendance: Club | 0.80 | 0.57 | 0.36 – 1.75 |
| Afrikaans | 0.42 | < 0.01 | 0.25 – 0.69 |
| English | 0.93 | 0.83 | 0.48 – 1.78 |
| Satisfaction mean score | 2.08 | < 0.01 | 1.24 – 3.50 |
Note: Estimated adherence in last 30 days (n = 285, adjusted for 13 clusters in clinic; pseudo R2 = 0.05).
, Xhosa used as the reference group.
Logistic regression model on adherence (last missed dose – adherent vs. non-adherent).
| Adherence | Odds ratio | 95% Confidence interval | |
|---|---|---|---|
| Attendance: Club | 1.30 | 0.49 | 0.60– 2.82 |
| Afrikaans | 0.20 | 0.01 | 0.06 – 0.68 |
| English | 0.32 | 0.02 | 0.12 – 0.86 |
| Years on ART | 0.85 | < 0.01 | 0.75 – 0.95 |
| Satisfaction mean score | 3.18 | < 0.01 | 1.14 – 7.11 |
| Viral suppression: Yes | 0.48 | 0.02 | 0.26 – 0.87 |
Note: Adherence (last missed dose) (n = 274, adjusted for 13 clusters in clinic; pseudo R2 = 0.1625).
ART, antiretroviral treatment.
, Xhosa used as the reference group.
Multiple regression model for mean satisfaction score.
| Satisfaction | Coefficient | 95% Confidence interval | |
|---|---|---|---|
| Attendance: Club | 0.22 | 0.05 | −0.004 – 0.444 |
| Afrikaans | 0.11 | 0.13 | −0.040 – 0.28 |
| English | 0.14 | < 0.01 | 0.040 – 0.25 |
| Number of other illnesses | −0.11 | 0.03 | −0.190 – −0.01 |
| Years on ART | 0.04 | 0.02 | 0.010 – 0.07 |
| Last missed dose | 0.04 | < 0.01 | 0.170 – 0.41 |
| Feeling well: No | −0.32 | 0.03 | −0.620 – −0.03 |
| Viral suppression: No | 0.16 | 0.07 | −0.010 – 0.32 |
Note: Satisfaction mean score n = 274, adjusted for 13 clusters in clinic; R2 = 0.212.
ART, antiretroviral treatment.
, Xhosa used as the reference group.